Bevacizumab/Paclitaxel Regimen

Preferred Label : Bevacizumab/Paclitaxel Regimen;

NCIt synonyms : Bevacizumab-Paclitaxel; Bevacizumab/Paclitaxel; Bevacizumab-Paclitaxel Regimen;

NCIt related terms : Paclitaxel and Bevacizumab; Paclitaxel and Bevacizumab-bvzr; Paclitaxel and Bevacizumab-adcd; Paclitaxel and Bevacizumab-equi; Paclitaxel and Bevacizumab-aybi; Paclitaxel and Bevacizumab-awwb; Paclitaxel and Bevacizumab-maly; Paclitaxel and Bevacizumab-onbe;

NCIt definition : A regimen consisting of paclitaxel and bevacizumab that may be used as a treatment for breast, ovarian, fallopian tube and primary peritoneal cancers.;

NCIt note : Source: NCCN Guidelines 2017;

NCI Metathesaurus CUI : CL524995;

Codes from synonyms : 7894; 127157; 127379; 127601; 127305; 127527; 127231; 127453;

Details

Origin ID

C138050;

UMLS CUI

C4522219;

Est indiqué pour
- Breast cancer metastatic [MedDRA Preferred Term]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Bevacizumab [NCIt concept]
- Paclitaxel [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients